TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Arco Lab now holds a 50% stake in Neviton
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Medway setup a state-of-the-art Heart Institute in Chennai
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
AMI to become part of Enpro’s Sealing Technologies Segment
Sirius JV will be owned 51% by Sirius and 49% by Adani
NEIAFMR to be developed as the national hub for folk medicine
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Subscribe To Our Newsletter & Stay Updated
